Critical and Comparative Analysis of the 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for Hypertension and Other International Guides and Protocols
Article Sidebar
Main Article Content
Abstract
The 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation, and management of arterial hypertension introduces important updates compared with the 2017 version. Given the global impact of hypertension as a major cause of cardiovascular morbidity and mortality, and the coexistence of multiple international and national recommendations, the Mexican Expert Group on Arterial Hypertension (GREHTA) conducted a structured review and comparative analysis. We contrasted the 2025 AHA/ACC recommendations with those of the European Society of Hypertension (ESH 2023), the European Society of Cardiology (ESC 2024), the Latin American Society of Hypertension (LASH 2024), and the National Medical Care Protocol of Mexico (PRONAM 2025). Our goal is to provide clinicians with a clear, evidence-based synthesis to guide practical decision-making. Key topics include definitions and thresholds, diagnostic methods, cardiovascular risk stratification, therapeutic strategies, special populations, and resistant hypertension. GREHTA emphasizes a pragmatic, regionally adapted approach, highlighting early combination therapy, risk factor integration, and systematic follow-up.
Article Details
Copyright (c) 2025 Alcocer L, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
1. Jones DW, Ferdinand KC, Taler SJ, Johnson HM, Shimbo D, Abdalla M, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2025:S0735-1097(25)06480-0. Available from: https://doi.org/10.1016/j.jacc.2025.05.007
2. Mancia G, Kreutz R, Brunström M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. 2023;41(12):1874-2071. Available from: https://doi.org/10.1097/hjh.0000000000003480
3. Sánchez R, Coca A, de Salazar DIM, Alcocer L, Aristizabal D, Barbosa E, et al. 2024 Latin American Society of Hypertension guidelines on the management of arterial hypertension and related comorbidities in Latin America. J Hypertens. 2025;43(1):1-34. Available from: https://doi.org/10.1097/hjh.0000000000003899
4. McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912-4018.
Available from: https://doi.org/10.1093/eurheartj/ehae178
5. Ministry of Health. National Medical Care Protocol (PRONAM) for Systemic Arterial Hypertension. Mexico: Ministry of Health; 2025. Available from: https://pronamsalud.csg.gob.mx/pronam-hipertension-arterial-sistemica.pdf
6. Palomo-Piñón S, Antonio-Villa NE, García-Cortés LR, Moreno-Noguez M, Alcocer L, Álvarez-López H, et al. Patients Living With Arterial Hypertension in Mexico: First Insights of The Mexican Registry of Arterial Hypertension (RIHTN Study). Am J Hypertens. 2024;37(7):503-513. Available from: https://doi.org/10.1093/ajh/hpae024
7. National Institute of Statistics and Geography (INEGI). Registered Death Statistics (EDR). February 25, 2025. Available from: https://www.inegi.org.mx/contenidos/saladeprensa/boletines/2025/edr/EDR_En-sep2024.pdf
8. Palomo-Piñón S, Alcocer L, Álvarez-López H, Cardona-Muñoz EG, Chávez-Mendoza A, Díaz-Díaz E, et al. Comparison of Globorisk, SCORE2, and PREVENT in the Stratification of Cardiovascular Risk and Its Relationship with End-Organ Damage Among Adults With Arterial Hypertension. J Clin Hypertens (Greenwich). 2025;27(8):e70106. Available from: https://doi.org/10.1111/jch.70106
9. Rosas-Peralta M, Mancia G, Camafort M, Galván-Oseguera H, Ferrario CM, Alcocer L, et al. Single pill combination therapy for hypertension: New evidence and new challenges: Combination Therapy for Hypertension. Trends Cardiovasc Med. 2025:S1050-1738(25)00082-9. Available from: https://doi.org/10.1016/j.tcm.2025.06.004
10. Borrayo-Sánchez G, Rosas-Peralta M, Guerrero-León MC, Galván-Oseguera H, Chávez-Mendoza A, Ruiz-Batalla JM, et al. Protocolo de Atención Integral: hipertensión arterial sistémica [Integrated Care Protocol: Hypertension]. Rev Med Inst Mex Seguro Soc. 2022;60(1):S34-S46. Available from: https://europepmc.org/article/med/35175695
11. Alcocer-Díaz-Barreiro L, Alcocer A, Álvarez-López H, Ancona-Vadillo AE, Antonio-Villa NE, Barquera S, et al. Metabolic-Adipose-Cardio-Arterial-Renal-Enterohepatic-neurological connection in arterial hypertension (MACARENHA): positioning for the new approach to prevention, diagnosis, treatment, and follow-up of patients living with arterial hypertension in Mexico. Cardiovasc Metab Sci. 2025;36(2):79-93.
Available from: https://www.medigraphic.com/pdfs/cardiovascuar/cms-2025/cms252a.pdf
12. Jurik R, Stastny P. Role of Nutrition and Exercise Programs in Reducing Blood Pressure: A Systematic Review. J Clin Med. 2019;8(9):1393. Available from: https://doi.org/10.3390/jcm8091393
13. Stamate E, Piraianu AI, Ciobotaru OR, Crassas R, Duca O, Fulga A, et al. Revolutionizing Cardiology through Artificial Intelligence—Big Data from Proactive Prevention to Precise Diagnostics and Cutting-Edge Treatment: Comprehensive Review of the Past 5 Years. Diagnostics (Basel). 2024;14(11):1103.
Available from: https://doi.org/10.3390/diagnostics14111103